IPAD-DB ID | C00907 |
Name | COS |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C O S |
Molecular Weight | 60.08 g/mol |
IUPAC Name | - |
InChI | InChI=1S/COS/c2-1-3 |
InChIKey | JJWKPURADFRFRB-UHFFFAOYSA-N |
Canonical SMILES | C(=O)=S |
PubChem CID | 10039 |
DrugBank Accession Number | - |
CAS Registry Number | 463-58-1 |
Molecular Weight(Computed by SwissADME) | 60.08 |
Hac(Computed by SwissADME) | 3 |
Volume(Computed by ADMETlab 2.0) | 47.879 |
Density(Computed by ADMETlab 2.0) | 1.253 |
nRing(Computed by ADMETlab 2.0) | 0 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 2 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -0.501 |
LogD(Computed by ADMETlab 2.0) | 0.523 |
logP(Computed by ADMETlab 2.0) | 1.094 |
TPSA(Computed by SwissADME) | 49.16 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.62 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 3 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 2 |
Bioavailability Score(Computed by SwissADME) | 0.55 |